Clinical course, social functioning, quality of life and medication toler-ability during three years of treatment: Final results from the schizophrenia outpatient health outcomes (SOHO)study

被引：0

作者：

Jones, PB

Novick, D

Brown, J

Suarez, D

Kennedy, L

Haro, JM

机构：

[1] Univ Cambridge, Dept Psychiat, Cambridge CB2 1TN, England

[2] Eli Lilly & Co, Windlesham GU20 6PH, Surrey, England

[3] San Joan Deu SSM, Res & Dev Unit, Barcelona, Spain

来源：

SCHIZOPHRENIA RESEARCH | 2006年 / 81卷

关键词：

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：60 / 60

页数：1

共 50 条

[41] Clinical status and tolerability profiles of previously untreated schizophrenia patients. 24-month results from the Pan-European SOHO (Schizophrenia Outpatient Health Outcomes) study
Novick, D
Haro, JM
Belger, M
Tzivelekis, S
Lepine, JP
Bushe, C
JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A10 - A10
[42] Comparison of olanzapine and quetiapine antipsychotic treatments for schizophrenia: Six-month results from the three-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study
Boland, J
O'Halloran, RA
Dossenbach, M
Levitt, L
Enatescu, V
Simon, L
Janu, L
SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 274 - 274
[43] Long-term maintenance of initial health related quality of life (HRQL) improvements gained through antipsychotic treatment: 24-month results from the Schizophrenia Health Outcomes (SOHO) study
Alonso, J
Novick, D
Belger, M
Brown, J
Ratcliffe, M
VALUE IN HEALTH, 2005, 8 (06) : A208 - A208
[44] Patient characteristics and clinical status of patients prescribed monotherapy or combination antipsychotic treatment: Baseline results from the intercontinental outpatient health outcomes study (IC SOHO)
Levitt, L
Becker, S
Dossenbach, M
Busselen, M
Png, CH
Lee, MH
Kim, CY
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S318 - S318
[45] Change in clinical status and side effects of patients treated with either olanzapine or risperidone:: Six-month results from the three-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study
Gargoloff, PR
O'Halloran, RA
Boland, JM
Brunner, E
Dossenbach, M
Levitt, L
Valencia, A
Landa, E
González, C
SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 283 - 284
[46] Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
Lee, Phil
Kim, Chul Eung
Kim, Chang Yoon
Lin, Wei-Wen
Habil, Hussain
Dyachkova, Yulia
Mcbride, Margaret
Dossenbach, Martin
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (03) : 215 - 227
[47] Psychiatric care and profile of schizophrenic outpatients treated by psychiatrists in France.: French baseline results from the 3-years, pan-European, observational SOHO (Schizophrenia Outpatient Health Outcomes) study
Rost, N
Gasquet, I
Lépine, JP
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S317 - S317
[48] Change in clinical status and side effects of patients treated with either olanzapine or risperidone: 6-month results from the 3-year intercontinental schizophrenia outpatient health outcomes (ic-soho) observational study
Osnayo, JL
Ibarra, RR
O'Halloran, RA
Boland, JM
Brunner, E
Levitt, L
Dossenbach, M
BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 28S - 29S
[49] Change in clinical status and side effects of patients treated with either olanzapine or risperidone: 6-month results from the 3-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study
O'Halloran, RA
Boland, J
Lee, PG
Dossenbach, M
Kim, CE
Jon, DI
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2003, 37 : A11 - A11
[50] Relationship between social support, functional outcomes and health-related quality of life in working-aged adults at three months after ischemic stroke: results from the FRAILTY study
Gurkova, Elena
Bartonickova, Daniela
Sanak, Daniel
Sanakova, Sarka
Zapletalova, Jana
Sturekova, Lenka
HEALTH AND QUALITY OF LIFE OUTCOMES, 2025, 23 (01)

← 1 2 3 4 5 →